Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-01-20 Lingnau Lutz Director Sale −15,000 $14.51 $218K 16,450
2016-01-20 Lingnau Lutz Director Exercise or conversion · Stock Option −15,000 0
2016-01-19 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +15,000 $6.65 $100K 18,999
2016-01-19 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −15,000 $14.12 $212K 3,999
2016-01-19 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −15,000 30,000
2016-01-19 ROBIN HOWARD W President & CEO Exercise or conversion +66,667 $6.46 $431K 76,667
2016-01-19 ROBIN HOWARD W President & CEO Sale −66,667 $14.12 $941K 10,000
2016-01-19 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −66,667 66,666

Page 55 of 55 · 1,088 trades